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After studying the epidemiologic transition’s situation in Canada, it is determined that 
the delimitation of temporal stages within the epidemiologic transition as put forward 
by Omran (1971, 1998), Olshansky and Ault (1986), Rogers and Hackenberg (1987) 
and  Olshansky  et  al.  (1998)  does  not  suit  the  Canadian  evolution.  Many  of  the 
researchers’ postulates on the epidemiologic transition were not confirmed, which leads 
us to assert that, since 1958, the epidemiologic transition in Canada is best described as 
an evolution process rather than specific stages confined within time limits.  
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1. Introduction 
The last century has been the witness to numerous changes in population evolution, 
including an important decline in fertility, paired with a regression of mortality due in 
part  to  the  changing  nature  of  causes  of  death.  The  study  of  the  theory  of  the 
epidemiologic  transition  has  allowed  better  insight  of  the  processes  behind  the 
evolution of mortality and causes of death in developed countries. However, this theory 
of the epidemiologic transition has also been a controversial issue among researchers in 
the last few decades. The object of this analysis is to study the evolution of the late 
stages of the epidemiologic transition in Canada, and to determine where Canada stands 




1.1 Social context in Canada 
Various socio-economic indicators like the Gross Domestic Product (GDP) and human 
development index rank Canada as one of the wealthiest and most developed nations in 
the world. Canada has also one of the highest life expectancies at 80.2 years old for 
combined sexes in 2004, which is 2.4 years higher than the United States’. Canada has a 
publicly  funded  health  care  system  where  the  government  contributes  70%  of  total 
health care costs. As a comparison, public funds cover 45% of health care expenses in 
the United States (OECD 2007). Moreover, immigrants make up a significant portion of 
the  population  as  19.8%  of  Canadian  residents  are  foreign-born,  which  is  over  7% 
higher than the official figure for the United States (Chui, Tran, and Maheux 2006). The 
large immigrant population bolsters Canada’s health indicators because immigrants are 
admitted  into  Canada  upon  their  health  status.  This  is  typically  referred  to  as  the 
“healthy immigrant effect”.  
 
 
1.2 The epidemiologic transition theory: Variants on the number of stages and 
their characteristics 
In  1971,  following  the  incomparable  decline  of  mortality  in  developed  countries, 
Omran put forward a theory describing for the  first time the decrease of infectious 
diseases, gradually replaced by chronic diseases. It  was labelled the “epidemiologic 
transition” and was initially comprised of three phases spread throughout the last few 
centuries describing this shift between the main causes of death. According to Omran, 
the first phase, called the “age of pestilence and famine” lasted until the middle of the 
19
th century and  was characterized by  high and fluctuating  mortality due  mostly  to Demographic Research: Volume 18, Article 19 
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infectious diseases. The second phase (the “age of receding pandemics”) ended in the 
middle of the 20
th century for most developed countries and is distinguished by the 
onset  of  the  shift  from  infectious  to  chronic  diseases,  and  the  increase  of  life 
expectancy.  The  third  phase,  identified  as  the  “age  of  degenerative  diseases”,  is 
characterized by the predominance of chronic diseases and the stabilization of mortality 
at a low level.  
In the mid-1980s, a fourth stage of the epidemiologic transition was suggested 
when researchers  found that, contrary to  what  Omran  had predicted, the decline of 
mortality  never  stopped  (Olshansky  and  Ault  1986;  Rogers  and  Hackenberg  1987). 
Subsequently, other researchers put forward variants or additions to the third stage of 
Omran and to the fourth stage of Olshansky and Ault (Olshansky et al. 1998; Omran 
1998; Robine 2001; Meslé and Vallin 2002).  
More specifically, Olshansky and Ault (1986) were the first to propose a fourth 
stage after observing an uninterrupted increase in life expectancy. They believed this 
trend was important enough to distinguish it from Omran’s three previous phases. The 
fourth stage suggested by Olshansky and Ault can be summarized by three general 
characteristics: 
 
i.  Rapidly declining death rates concentrated mostly in advanced ages and 
occurring at nearly the same pace for males and females; 
ii.  A  relatively  unchanged  age  pattern  of  mortality  by  cause,  but  a 
progressive shift towards older ages of the age distribution of deaths by 
degenerative causes; and 
iii.  Relatively  rapid  movements  in  survival  concentrated  among  the 
population in advanced ages. 
 
This  fourth  stage  is  referred  to  as  the  “age  of  delayed degenerative  diseases”. 
When Olshansky and Ault published their article in 1986, they argued that the USA had 
already entered the fourth stage of the epidemiologic transition, although a time-frame 
was not specified.  
In 1998, Omran recognized the existence of one and possibly two additional stages 
to his initial theory of the epidemiologic transition. According to Omran, the fourth 
stage is characterized by an ongoing rise in life expectancy until it reaches 80 to 85 
years old; by a stabilization, then a decrease, of cardiovascular diseases as a cause of 
death; as well as by the emergence of new diseases (HIV; hepatitis B and C; Ebola; 
Lyme disease; Hantaan virus; new forms of E.Coli, etc.) and by the revival of former 
diseases  (cholera;  malaria;  dengue;  diphtheria;  tuberculosis;  plague;  and  Chagas 
disease).  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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Rogers and Hackenberg (1987) also proposed a fourth stage of the epidemiologic 
transition. They agreed with Olshansky and Ault that degenerative diseases remain the 
leading cause of death, but their main argument against Omran’s original theory is the 
fact that the evolution of violent deaths (or deaths due to social pathologies: mainly 
accidents, suicides, and homicides) were not included in his theory.  
Robine (2001) has been even harsher than the previous researchers in his critique 
of the theory of the epidemiologic transition. Particularly, Robine has doubted the very 
existence of the last two stages (Omran’s stage of degenerative diseases and Olshansky 
and  Ault’s  stage  of  delayed  degenerative  diseases)  after  studying  the  evolution  of 
dispersion of life spans.  
For Meslé and Vallin (2002), the epidemiologic transition is comprised of two 
stages, and perhaps a third. They have acknowledged Omran’s first stage during which 
the improvement in survival is due mostly to the collapse of infectious diseases and to 
the rise of chronic diseases. They believe that the second and last stage takes place 
when the growth of life expectancy starts being sustained almost entirely by the decline 
of  cardiovascular  diseases.  They  have  referred  to  this  stage  as  the  “cardiovascular 
revolution”. They have also suggested that by pushing back life expectancy incessantly, 
women of the most developed countries might have entered a third stage, described as 
the “fight against ageing” (Vallin and Meslé 2004).  
A variety of other researchers have also published their analysis of the existence, 
evolution or attributes of the epidemiologic transition (Meslé 1997; Fetter 1997; Rogers 
and Nelson 1997; Mackenbach 1994; Caselli and Egidi 1991; Burgio and Frova 1995). 
Since this theory has been fuelling debate over the last few decades, we deemed it 
pertinent to clarify the status of the epidemiologic transition in Canada.  
 
 
1.3 The empirical work in Canada 
A few Canadian studies have attempted to determine whether Canada has experienced 
the theoretical assertions of the epidemiologic transition’s late stages.  
Nagnur and Nagrodski’s analyses (1987; 1990) showed that the evolution of the 
epidemiologic transition described by Omran could be observed for Canada between 
1931 and 1981, but they did not venture on the status of the fourth stage, or provide 
temporal indications on the switch from the second to the third stage or from the third 
to the fourth. However, Bah and Rajulton (1991) claimed that Nagnur and Nagrodski’s 
research (1987; 1990) showed that Canada reached the third stage of the epidemiologic 
transition  in  the  1950s,  even  though  Nagnur  and  Nagrodski  themselves  did  not 
explicitly give any estimation on that matter. The ambiguity of these statements has 
prompted us to clarify the Canadian situation.  Demographic Research: Volume 18, Article 19 
http://www.demographic-research.org  535 
1.4 Research questions 
Before discussing the core of our research analysis, we will establish more precisely 
when Canada made the transition from Omran’s second to third phase. Because there is 
no consensus among researchers on  what happens beyond Omran’s third stage, our 
research objectives focus primarily on that matter. The following questions are inspired 
by the allegations brought up by researchers:  
 
1.  Was mortality’s decline concentrated mostly in advanced ages and did the 
decline occur at nearly the same pace for males and females? (Olshansky 
and Ault 1986) 
2.  Did the pattern of mortality by cause become stable (Olshansky and Ault 
1986)?  
3.  Did specific changes occur within chronic disease groups?  
4.  Did a gradual shift towards older ages take place in mortality by chronic 
diseases? (Olshansky and Ault 1986) 
5.  Did  mortality  by  social  pathologies  decline?  (Rogers  and  Hackenberg 
1987) 
6.  Was the impact of AIDS on mortality significant? Did a resurgence of 
infectious  diseases  like  cholera,  diphtheria  and  dengue  take  place?
4 
(Omran 1998)  
7.  Did mortality due to pneumonia and influenza increase? (Olshansky et al. 
1998) 
 
All  questions  arise  from  researchers  who  have  worked  on  the  epidemiologic 
transition  except  the  third,  relating  to  possible  changes  taking  place  within  chronic 
diseases.  Because  the  evolution  of  cardiovascular  mortality  is  fully  examined  by 
questions 2 and 3, Meslé and Vallin’s proposal (2002) on the cardiovascular revolution 
has not been included. Meslé and Vallin’s suggestion is referred to in the conclusion.  
After assessing each of  the  research questions,  we  will  be better positioned to 
provide a verdict on the status of the epidemiologic transition in Canada.  
 
 
                                                            
4 Cholera, diphtheria and dengue are three of the infectious diseases identified by Omran (1998) as having a 
comeback. We chose these three diseases over others for two reasons: the compatibility between ICD-7, 
ICDA-8 and ICD-9 are the least complex for these three diseases; in addition, diphtheria and dengue are two 
of the four infectious diseases that Olshansky et al. (1998) believe are resurfacing in North America.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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2. Data and methods 
2.1 Period of study and data 
The analysis starts in 1958, which is the first year of the 7
th revision of the International 
Classification of Diseases (ICD) in Canada, and which falls shortly before the slowing 
down of the decline of mortality observed in the 1960s (Bourbeau and Smuga 2003; 
Chasteland and Chesnais 1997). The final year of the analysis is 1999, which is the last 
year of the 9
th revision of the ICD in Canada. In fact, the largest difficulty met in this 
research was the revision changes of the ICD.  
Statistics Canada provided the data on causes of death. The data was available by 
5-year age groups (0-1, 1-4, 5-9, 10-14, …, 100+), by sex, and the causes of death were 
classified by 4-digit rubrics. The under-estimation of deaths is very low considering the 
requirement of death registering, and is mainly due to a delay of registration rather than 
an omission.  
 
 
2.2 Definitions  
When  Omran  described  his  epidemiologic  transition  theory,  he  used  the  term 
“degenerative  diseases”  without  describing  which  diseases  that  term  encompasses. 
Researchers  working  on  the  epidemiologic  transition  subsequently  adopted 
“degenerative  diseases”  without  questioning  its  definition.  Later,  the  expression 
“chronic  diseases”  became  increasingly  used  to  define  the  most  prevalent  diseases 
within the population.  
The  term  “chronic  diseases”  will  be  used  in  this  analysis  because  it  is  more 
widespread in the literature, and has a universal and renowned definition in dictionaries, 
encyclopaedias  and  medical  literature  as  well  as  among  researchers  working  in  the 
public  health  field.  For  this  analysis,  chronic  diseases  include  six  disease  groups 
unanimously identified as such by numerous sources:  malignant tumours (cancer or 
neoplasm); cardiovascular diseases; diabetes; chronic obstructive pulmonary diseases 
(COPD
5);  osteo-articular,  muscular  and  conjunctive  tissue  diseases  (which  include 
osteoporosis and arthritis); and  Alzheimer’s disease (Wolleswinkel-Van  Den Bosch, 
J.H. et al. 1996; Santé Canada 2004; Ministère de la Santé et des Services Sociaux du 
Québec 2005; Center for Diseases Control and Prevention 2007; Brownson, R.C. et al. 
1993;  Trowell,  H.C.  and  Burkitt,  D.P.  1981).  Therefore,  when  discussing  “chronic 
diseases” without further detail, we will be referring to these six groups of diseases. 
                                                            
5 COPD examined: emphysema, asthma and chronic bronchitis. Demographic Research: Volume 18, Article 19 
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Suicides, homicides and accidents comprise the main causes of death of Rogers and 
Hackenberg’s “social pathologies”.  
 
 
2.3 Causes of death and compatibility in the long-term: The international 
classification of diseases and its revisions 
Two steps must be taken with great circumspection in the study of the epidemiologic 
transition: the choice of causes of death to be analyzed and their follow-up in the long-
term.  
We  converted  the  causes  of  death  of  the  7
th,  8
th  and  9
th  revisions  of  the 
International  Classification  of  Diseases  (ICD-7,  ICDA-8  and  ICD-9)  to  make  them 
compatible.  For  major  ICD  revisions,  Statistics  Canada  and  the  World  Health 
Organisation  (WHO)  provide  some  basic  documents  to  help  make  the  transition 
between  the  old  and  new  revision.  Many  other  countries  are  faced  with  the  same 
problem,  namely  the  scarcity  of  manuscripts  that  detail  the  change  of  revisions 
(Wolleswinkel-Van Den Bosch et al. 1996). Since a complete cross-walk of codes is not 
available, the reclassification needs to be completed a posteriori (Vallin and Meslé 
1996).  
Moreover, Statistics Canada and various researchers have warned that tackling the 
discontinuity of ICD’s sequences can be complex and needs to be approached with 
caution (Statistique Canada  1984; Meslé 1997). Fortunately, Vallin and Meslé have 
published a document establishing the compatibility of the statistical series between 
ICD-7 and ICDA-8; but their work is still in progress for the changes introduced by 
ICD-9 (Vallin and Meslé 1996). We have used their model to ensure the compatibility 
of our causes of death between the 7
th and 8
th revision of the ICD, but no work as 
exhaustive as Vallin and Meslé’s (1987) has been published for the reconstruction of 
sequences between ICDA-8 and ICD-9. However, we have created a fairly accurate 
match between ICDA-8 and ICD-9 with the help of an article (Vallin and Meslé 1996) 
and a non-published report from Statistics Canada.   
Making  sure  the  causes  of  death  used  in  this  research  paper  were  compatible 
through  the  three  revisions  of  the  International  Classification  of  Diseases,  and 
converting  all  the  data  into  the  9
th  revision  standards,  was  a  delicate  process.  The 
compatibility between the causes of death through time might not be perfect, but we 
believe that the work has been done with as much thoroughness as necessary.  
 
 Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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3. Results 
3.1 The third phase of the epidemiologic transition in Canada 
The shift from the second to the third stage in Canada did not arouse much interest from 
researchers. Most had assumed that this transition was completed by the middle of the 
20
th century. Since our research questions relate to what happens after the third stage, it 
is essential to determine with more precision when the change from the second to the 
third stage took place.  
We  used  two  of  Omran’s  main  attributes  describing  the  third  stage:  the 
predominance of mortality by chronic diseases, and the stabilization of mortality at a 
low level. Since Omran did not state exactly what he implied by predominance, we 
assumed  in  the  context  of  this  study  that  the  predominance  started  when  chronic 
diseases cause 50% or more deaths. The stabilization of mortality at a relatively low 
level is analyzed with standardized mortality rates.  
The time frame examined to determine the period during which chronic diseases 
started their preponderance is 1921 until 1999, thus covering ICD-3 to ICD-9. Eight 
categories  of  chronic  diseases  were  selected  for  this  time  frame:  cancer;  diabetes; 
cerebral  haemorrhage,  embolism  and  thrombosis  (from  1921  to  1968);  circulatory 
system  diseases;  chronic  bronchitis;  asthma;  pulmonary  emphysema;  and  bone  and 
movement organ diseases. We understand that the compatibility of chronic diseases 
between  ICD-3  and  ICD-9  is  imperfect,  but  is  adequate  since  the  objective  of  this 
section is solely to identify the approximate period of transition between the second and 
third stages.  
 Demographic Research: Volume 18, Article 19 
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Sources: Dominion Bureau of Statistics, 1923-1947. Bureau fédéral de la statistique, 1948-1969. Statistique Canada, Catalogues 84-
206 (1970-1986), 84-204 (1978-1986), 82-003S (1987-1989), 82-003S15 (1989-1990), 82-003S11 (1990), 84-208 (1991-1993), 
84-211 (1991-1992), 84-210-XPB (1993-1995), 84-208-XPB (1994-1995), 84-209-XPB (1995-1999), 84F0210XPB (1996-1997), 
84F0208 (1996-1999), 84F0211XPB (1998-1999). 
 
Figure 1 shows that chronic diseases began to cause half of female deaths in 1941; 
the men’s trend followed four years later. Therefore, this first aspect of the third stage 
of the epidemiologic transition started towards the middle of the 1940s in Canada.  
As far as Omran’s second criteria, figure 2 reveals that mortality never completely 
stabilized. Until the middle of the 1940s, standardized rates
6 evolved erratically, but the 
overall trend  was definitely  declining. The drop has been steady during the last 50 
years. There have been short interruptions in the reduction of mortality, but they have 
not been long enough to classify as stagnation.  
 
                                                            
6 We used the direct standardization method and employed the Canadian population in 1996 as the reference 
population. We obtained the expected deaths by multiplying age-specific mortality rates of each year by the 
same age-specific reference population.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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Sources: Same as figure 1. 
 
Overall, we can assert that one of the two criteria describing the switch from the 
second to the third stage took place, which is the one regarding the predominance of 
chronic  diseases.  The  stabilization  of  mortality  criterion  did  not  occur.  There  was 
indeed a slowing down of the decrease of mortality during the 1950s and 1960s, but the 
decline  never  completely  stopped.  The  invalidation  of  Omran’s  second  criterion 
compels  us  to  reject  the  third  stage  as  he  had  initially  suggested  it,  in  the  case  of 
Canada. Nevertheless, the mere fact that chronic diseases emerged so clearly indicates 
the beginning of a third stage of the epidemiologic transition which, although not the 
one suggested by Omran.  
 
 
3.2 The sequel to the third stage in Canada  
The purpose of this study is to clarify the evolution of the epidemiologic transition 
since the beginning of the third stage in Canada. Since only one of Omran’s two criteria 
describing the third stage can be observed for Canada, the main focus is on further 
development since the epidemiologic transition seems to extend beyond the beginning Demographic Research: Volume 18, Article 19 
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of the third stage. Although we understand that the results depend on the indicators 
selected,  we believe that if no ambiguity is associated with the results, all possible 
indicators would have probably come to equivalent conclusions.  
 
 
3.2.1 Was mortality’s decline concentrated mostly in advanced ages and did the 
decline occur at nearly the same pace for males and females? (Olshansky and Ault 
1986) 
The first sign of the delay of the degenerative diseases stage, suggested by Olshansky 
and Ault in 1986, is a decrease of mortality, which occurs primarily among the elderly 
and at the same pace for men and women. In breaking down life expectancy by age 
groups,  a  decline  of  mortality  can  be  estimated,  and  the  age  groups  that  have 
contributed the most to the gain of life expectancy at birth between 1958 and 1999 can 
be evaluated as well.  
As expected, the decline of mortality is confirmed throughout the entire period by 
a  continuously  growing  life  expectancy  (table  1).  Table 1  was  calculated  using  the 
Arriaga  method  (Arriaga  1984).  The  Arriaga  method  calculates  the  contribution  of 
different age groups to the increase in life expectancy at birth.
7 Results differ greatly 
between men and women during the period 1958-1979. The growth of the male life 
expectancy between 1958 and 1979 is much more attributable to the decline of infant 
mortality than to the decrease of mortality among older ages. But this is not the case for 
women. Even though the decline of mortality at young ages was not negligible in the 
increase of female life expectancy between 1958 and 1979, the input of the older age 
groups to their life expectancy growth proved to be more significant.  
 
 
                                                            
7 The Arriaga method is a way to decompose life expectancy between two periods to see which age groups 
contribute the most to the variation of life expectancy. It is calculated from life tables, and it estimates from 
lx, Lx and Tx, which age groups contributed the most to the gain or loss of life expectancy between periods.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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Table 1:  Contribution of age groups (in years and in percent) to the increase 
in life expectancy at birth, men and women, Canada,  
1958-1979 and 1979-1999 
1958-1979  1979-1999 
Men  Women  Men  Women 
Age groups 




  1.4  28.5  0.5  10.5  0.4  13.1 
1-14 years 
0.3  9.9  0.3  5.5  0.3  5.1  0.2  6.3 
15-34 years 
0.0  -1.0  0.1  2.3  0.6  13.2  0.2  7.8 
35-64 years 
0.8  24.8  1.0  19.5  2.1  43.1  1.0  33.8 
65 years + 
0.6  18.8  2.2  44.2  1.4  28.2  1.2  39.1 
Total 
3.4  100.0  4.9  100.0  4.9  100.0  3.1  100.0 
 
Source: Canadian Human Mortality Database, 2004. 
 
Between 1979 and 1999, women aged 65 years and over contributed to a lesser 
degree  in  the  increase  of  life  expectancy  than  the  previous  period,  but  the  growth 
remained  the  highest  amongst  this  age  group.  As  for  men,  their  situation  evolved 
significantly during the second time frame. The input of older age groups escalated 
compared to the prior period, but was once again exceeded by the adult age group (34-
64 years), which showed the most significant mortality decrease.  
Since  the  results  regarding  the  preponderant  contribution  of  the  elderly  to  the 
improvement of survival are not completely conclusive, we decided to examine what 
the outcome would be for the most recent period, 1990-1999. The results suggest that 
35% of men’s life expectancy increase recorded between 1990 and 1999 is attributable 
to greater survival among people aged 65 years and over. For the same period, the 
improvement of survival among elderly females compared to the other age groups was 
even greater since their input on the growth of life expectancy stood at 45%.  
The second part of the hypothesis, the decline of mortality occurring at the same 
pace for men and women, can be partly assessed by figure 1. During the first half of the 
period, the decrease of female mortality is more pronounced.  Nevertheless, between 
                                                            
8 The infant mortality rate among Canadian men dropped from 3,602 per 100,000 in 1958 to 1,253 per 
100,000 in 1979. This decline of almost 200% was the most important age-specific mortality rate decrease in 
men in this time period. The many young lives saved between 1958 and 1979 contributed the most to the 
surge in male life expectancy.  Demographic Research: Volume 18, Article 19 
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the middle of the 1970s and 1999, the decline of mortality among men accelerates and 
that of women’s slows, which brings the two mortality curves closer together. These 
trends are confirmed by table 2, which shows the variations of standardized mortality 
rates and of life expectancy at birth during the periods 1958-1999, 1958-1979 and 1979-
1999. Both indicators reveal that the reduction of mortality is favourable to women 
between 1958 and 1979 and to men from 1979 to 1999.  
 
Table 2:  Variation of life expectancy at birth (increase in years) and of 
standardized mortality rates decrease (in percent) by sex, Canada, 
1958-1999, 1958-1979, 1979-1999 
1958-1999  1958-1979  1979-1999  Variations in: 
Men  Women  Men  Women  Men  Women 
Life 
expectancy 




36.4  44.7  16.8  32.0  23.6  18.7 
 
Sources: Canadian Human Mortality Database, 2004; Statistics Canada, Cat. 91-209F, 2002.  
 
 
3.2.2 Did the pattern of mortality by cause become stable (Olshansky and Ault, 
1986)?  
One  of  the  conditions  to  Olshansky  and  Ault’s  fourth  stage  is  that  the  pattern  of 
mortality  by  cause  stays  unchanged,  but  that  the  age  distribution  of  deaths  due  to 
chronic diseases is progressively shifted toward older ages.  
 
 
Distribution of deaths by cause 
The  proportions  of  causes  of  death  through  time  are  analyzed  in  order  to  estimate 
whether the pattern of causes of death remained roughly the same. Figure 3 reveals that, 
between 1958 and 1999, the main alteration was the gradual reduction of the supremacy 
of  cardiovascular  diseases  (CVD),  which  were  mostly  replaced  by  the  increasing 
prevalence of cancer. The weight of “other diseases” among the totality of causes of 
death lessened, as well as that of traumas (mainly accidents, suicides and homicides) Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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which, however, recorded an increase of their importance in mid-period before starting 
their descent. After completely disappearing in the early 1980s, infectious and parasitic 
diseases (IPD) resurfaced following the emergence of AIDS. Similarly, the importance 
of respiratory diseases slightly intensified, as well as that of diabetes and Alzheimer’s 
disease. Alzheimer’s disease, however, was not acknowledged until the introduction of 
ICD-9. The significance of digestive system diseases among all causes of death was 
quite stable throughout the entire period.  
 












































































































Sources: Bureau fédéral de la statistique, 1958-1969. Statistique Canada, Catalogues 84-206 (1970-1986), 84-204 (1978-1986), 82-
003S (1987-1989), 82-003S15 (1989-1990), 82-003S11 (1990), 84-208 (1991-1993), 84-211 (1991-1992), 84-210-XPB (1993-




Standardized mortality rates by cause 
The standardized mortality rates by cause are examined in order to extend the analysis 
of the pattern of causes of death. Mortality rates were split into two figures representing Demographic Research: Volume 18, Article 19 
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standardized mortality rates for the broad causes of death in figure 3, to ensure a clearer 
reading of the trends.  
The steady decline of mortality by cardiovascular diseases in figure 4 is striking. 
The probability of dying from a cardiovascular disease has decreased significantly: the 
mortality  rate  dropped  from  670 per  100 000  in  1958  to  250  per  100 000  in  1999. 
Mortality rates by cancer have actually risen slightly despite the reduction of overall 
mortality since 1958. The combination of these two trends caused the two mortality 
curves to border each other by the end of the period, which would have been considered 
highly impossible in the late 1950s since the standardized mortality rate of CVD at that 
time was 3.5 times that of tumours. 
 
 
Figure 4:  Standardized mortality rates by cardiovascular diseases (CVD) and 
















































































































Sources : Deaths : Bureau fédéral de la statistique, 1958-1969. Statistique Canada, Catalogues 84-206 (1970-1986), 84-204 (1978-
1986), 82-003S (1987-1989), 82-003S15 (1989-1990), 82-003S11 (1990), 84-208 (1991-1993), 84-211 (1991-1992), 84-210-
XPB (1993-1995), 84-208-XPB (1994-1995), 84-209-XPB (1995-1999), 84F0210XPB (1996-1997), 84F0208 (1996-1999), 
84F0211XPB (1998-1999). Populations: Statistique Canada, Catalogues 91-512 (1921-1971), 91-518 (1971-1986), 91-210 
(1987-1992), 91-213 (1993-1994), 91-213-XPB (1995-1999). 
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Figure  5  reveals  that  violent  and  accidental  mortality  decreased  considerably 
starting  in  the  1970s.  The  evolution  of  mortality  by  respiratory  diseases  was  more 
irregular, but the general trend was a decline as well. By the end of the 20
th century, a 
Canadian was more likely to die from a respiratory disease than from an accident or a 
trauma, whereas these probabilities were more or less equal at the beginning of the 
period.  
The standardized mortality rate from digestive system diseases fell steadily over 
the entire period. Moreover, mortality rate from diabetes first decreased in the 1970s, 
and then had a modest increase beginning in the 1990s. The emergence of AIDS had a 
surprising impact on standardized mortality rate by infectious and parasitic diseases 
(IPD). Between 1986 and 1991, the mortality rate from IPD doubled. It continued rising 
until 1995, then dropped substantially. Mortality rate from Alzheimer’s disease soared, 
even though the standardized rate eliminates the aging effect of the population. The 
progress was quite astonishing: the rate was multiplied by nine in only twenty years
9.  
 
                                                            
9 This growth is biased by the fact that Alzheimer’s disease was not introduced into the ICD until 1979, and 
by the fact that this disease has been a popular diagnosis among doctors needing to determine the initial cause 
of death (Vallin and Meslé 1996).  Demographic Research: Volume 18, Article 19 
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Figure 5:  Standardized mortality rates by traumas, respiratory diseases, 
digestive system diseases, infectious and parasitic diseases (IPD), 

















































Sources: Same as figure 4. 
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3.2.3 Did specific changes occur within chronic diseases groups? 
When Olshansky and Ault suggested that the pattern of causes of death remained more 
or less unchanged between the third and fourth phases, they did not account for the 
possible variations occurring within groupings of causes of death. It was found that 
Olshansky and Ault’s second hypothesis was not corroborated. We will go even further: 
not only did the pattern of large groups of causes of death not remain stable, but there 
were specific changes within these same large groups of causes of death. Three major 
groups of chronic causes of death were assessed: cardiovascular diseases, cancer and 
respiratory diseases.  
Malignant tumours were studied according to the sex since men and women have 
different seats of cancer, and usually have a cancer pattern of their own. Four sub-
categories were created for men and five for women (figures 6 and 7). Cancer of the 
respiratory system among men increased significantly until the 1980s, after which their 
weight among tumours stabilized, then slightly decreased at the end of the last century. 
The  growing  importance  of  respiratory  system  tumours  among  men  was 
counterbalanced by the decrease of cancer of the digestive system.  
Women’s mortality rates by cancer had similar transformations but, unlike men, 
their digestive system tumours remained dominant throughout the entire period despite 
an exceptional increase in the importance of respiratory system tumours starting in the 
early 1970s (figure 7). Moreover, the importance of genito-urinary cancers dropped by 
half between 1958 and 1999, that of breast cancer decreased by 3% and that of “other 
tumours” went from 18% to 23% of the total amount of tumours.  
Even though the use of tobacco in Canada has seen a significant decrease between 
1971 and 2005, dropping from 49% to 19% for men and from 30% to 15% for women, 
the importance of respiratory tumours for both sexes can be explained by the fact that 
the onset of cancer occurs decades after exposure to carcinogenic agents. Therefore, the 
importance of respiratory tumours in the 1990s is directly related to the use of tobacco 
in the 1960s and 1970s (OECD 2007).  
As  for  cardiovascular  diseases,  the  only  clear  change  between  1958  and  1999 
proved  to be  the  significant  decrease  of  hypertensive  diseases  (not  illustrated).  The 
incidence of ischemic cardiopathies and of cerebro-vascular diseases within all CVD 
slightly declined, whereas that of “other diseases” grew considerably.  
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Figure 6:  Distribution of deaths by cancer according to the type of cancer, 
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Sources: Same as figure 4.   
 
Figure 7:  Distribution of deaths by cancer according to the type of cancer, 
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Sources: Same as figure 4.   
Diseases of the respiratory system were split into three groups (not illustrated): 
pneumonia  and  influenza;  chronic  obstructive  pulmonary  diseases  (emphysema, 
asthma, chronic bronchitis); and other. The general trend was characterized by a steady 
decrease in the proportion of pneumonias and influenza and, in return, by an increase of 
chronic  obstructive  pulmonary  diseases.  The  weight  of  the  latter  within  the  whole 
respiratory diseases group was constant during the last twenty years of the period and 
comprised about half of deaths.   
 
 
3.2.4 Did a gradual shift towards older ages take place in mortality by chronic 
diseases? (Olshansky and Ault 1986) 
Olshansky and Ault’s last hypothesis consisted of a postponement of age at death by 
chronic diseases. According to them, this delay would neither be caused by a reduction 
of chronic diseases’ incidence, nor by a deferment of age at which chronic diseases 
develop. This shift of age at death towards older ages, if it takes place, would be due to 
a  prolonging  of  survival  with  chronic  diseases;  in  other  words  to  an  expansion  of 
morbidity.  
Two indicators are used in order to bring to light the validity of this premise. The 
mean age at death by chronic diseases is used, calculated from standardized rates by age 
so that the aging of population bias is eliminated. The distribution of deaths by chronic 
diseases according to age is also examined.  
 
 
Mean age at death by chronic diseases  
Figure 8 shows that the mean age at death did increase fairly steadily for all chronic 
causes of death. Alzheimer’s disease clearly stands out with an age at death far higher 
than any other cause of death throughout the entire period, even though the general 
trend was a declining slope in the first twenty years. In 1999, the mean age at death 
from Alzheimer’s disease was nearly 85 years.  
The most striking and continuous growth of age at death belongs undoubtedly to 
chronic  obstructive  pulmonary  diseases  (COPD).  The  age  at  death  of  individuals 
suffering from COPD increased by 8.5 years (from 70.2 to 78.7 years) over the study 
period.  Cardiovascular  diseases  had  the  2
nd  highest  increase  in  mean  age  at  death, 
although the increase was only 2.5 years over 42 years.  
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Figure 8:  Mean age at death by chronic diseases, both sexes, Canada,  






























































































Sources: Same as figure 4.  
 
Even though the evolution of the mean age at death from osteo-articular diseases 
was quite irregular, it grew significantly and, at 77.5 years in 1999, it was about average 
compared to the other chronic diseases. In addition, the mean age at death from diabetes 
was 75 years at the end of the period, which ranks that disease second to last. The 
growth of its mean age at death between 1958 and 1999 was 4.3 years, which is the 
average.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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Finally, the mean age at death by tumours trails at the bottom throughout the entire 
interval. The average age at death for an individual suffering from cancer only grew 
from 68.1 to 70.6 years from 1958 to 1999.  
 
 
Distribution of deaths by chronic diseases according to age 
The deaths were distributed into three large age groups: 0-64 years, 65-84 years and 85 
years and over. The proportion of standardized deaths by age groups was compared for 
each of the chronic disease groups (this is noted in each paragraphs below).   
There were no major disruptions in the proportions of standardized deaths by age 
and by cardiovascular diseases over time, although there was a visible delay especially 
among people aged 85 years and over (not illustrated). In other words, individuals aged 
85 years and older made up a greater proportion of total deaths by CVD at the end of 
the time span than at the beginning.  
The  age-specific  portrayal  of  Canadians  dying  from  malignant  tumours  is 
surprisingly invariable (not illustrated). The weight of deaths from people aged 65 years 
and less had the most notable change with a decrease of 7%. Moreover, the Canadian 
population aged 85 years and over succumbed of cancer as much in 1999 as they did in 
1958.  This  undermines  the  theory  of  the  transition  towards  older  ages  of  death  by 
cancer.  
As illustrated by figure 9, deaths by chronic obstructive pulmonary diseases are 
characterized by a switch of proportions between people aged less than 65 years and 
those  aged  85  years  and  more  during  the  interval.  Therefore,  the  85+  age  group 
supplanted the 0-64 age group as the second age category  with the most deaths by 
COPD.  
The evolving age distribution of deaths by diabetes, however, clearly indicates a 
transition of death at older ages. The proportion of deaths fell for both the 65-84 and the 
less than 65 years age groups. The 85+ age group absorbed these numbers.  
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Figure 9:  Standardized age distribution of deaths by chronic obstructive 
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Sources: Same as figure 4.  
 
Alzheimer’s disease and osteo-articular,  muscle and conjunctive tissue diseases 
most  clearly  reflect  the  transition  to  older  ages  at  death.  As  with  diabetes,  the 
Alzheimer’s age group 85+ was the only one that increased in proportion between 1958 
and 1999. Alzheimer’s disease is also the only chronic affliction where most deaths 
occur after 85 years old. As for diseases of the osteo-articular system, the weight of the 
age  group  85+  more  than  doubled  (from  16%  to  34%)  and  the  proportion  of  the 
youngest age group (0-64) tumbled from 30% to 16%.  
 
 
3.2.5 Did mortality by social pathologies decline? (Rogers and Hackenberg 1987) 
In  addition  to  Olshansky  and  Ault  (1986),  Rogers  and  Hackenberg  (1987)  also 
suggested a fourth stage of the epidemiologic transition. We examined their hypothesis 
that there would be a decrease of mortality by social pathologies. Social pathologies 
typically  refer  to  mortality  caused  by  accidents  and  homicides,  and  also  to  deaths Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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caused  by  lifestyle,  such  as  suicides,  liver  disease  induced  by  alcoholism  and  lung 
disease brought on by tobacco use. For the purpose of this study, accidents, homicides 
and suicides were analyzed.  
Figure 10 illustrates the evolution of standardized mortality rates for accidents, 
suicides and homicides. It suggests that accidental deaths clearly lead as the main cause 
of death from social pathologies throughout the entire period. All the same, mortality 
due to accidents started decreasing rapidly in the early 1970s. In the 1990s, it was still 
declining, but at a slower rate. Between 1973 and 1999, the accidental mortality rate 
was cut in half.   
 
 






































































Sources: Same as figure 4.  
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Mortality  by  suicide  slightly  increased  over  the  entire  interval.  The  growth  of 
mortality  by  suicide  was  more  impressive  during  the  first  half  of  the  period.  The 
pronounced decrease of mortality by accidents, combined with suicide rates that have 
been nearly unchanged since the 1980s, brings the two curves closer together. In 1958, 
the Canadian population had six times more risks of dying from an accident than from a 
suicide, but in 1999 the same ratio had dropped to two.  
As for homicides, they are the least frequent social pathology during the whole 
period.  Like  mortality  by  accidents  and  by  suicide,  homicides  have  seen  their 
standardized mortality increase as well in the 1970s. After reaching their culminating 
point at 2.6 deaths per 100 000 in 1977, mortality by homicide declined slowly. At the 
end of the century, the standardized mortality rate by homicide was at the same level as 
it was at the end of the 1960s.  
 
 
3.2.6 Was the impact of AIDS on mortality significant? Did a resurgence of 
infectious diseases like cholera, diphtheria and dengue take place? (Omran 1998)  
In 1998, Omran also proposed a fourth stage, in addition to his three initial stages. It is 
characterized, among other things, by the emergence of new infectious diseases and by 
the reappearance of former infectious diseases. Although this fourth stage described by 
Omran was aimed mostly at developing countries, he also mentioned that developed 
countries should keep an eye on the evolution of AIDS, cholera, diphtheria and dengue. 
The impact of these four diseases in Canada since 1958 is examined.  
There has not been a resurgence of cholera, diphtheria and dengue in Canada. The 
last death attributable to cholera in Canada goes back to 1959; two Canadians died from 
dengue between 1958 and 1999; and diphtheria caused a total of 95 deaths during the 
same period.  
On the other hand, the surfacing of AIDS, which first attributable death occurred 
in 1983 in Canada, had a small repercussion on the overall Canadian mortality. The 
effect of the onset of AIDS on women’s mortality was not significant, as the mortality 
rate by AIDS among females never reached 2 per 100 000. However, the impact of 
AIDS on male mortality was not trivial. After rising to 11 deaths per 100 000 in 1995, 
men’s  mortality  rates  by  AIDS  started  declining  astoundingly  and,  in  1999,  their 
mortality rate was a fifth of what it was in 1995.  
AIDS did not affect all age groups in the same way.  For each age group, the 
proportions of deaths due to AIDS are illustrated by a Lexis surface (figure 11). The 
Lexis surface is a 3-dimension figure, with the dimensions being age (y axis), years (x 
axis), and the degree of intensity of the trend (colors inside the graph). The colored 
scale represents the degrees of intensity, in this case, the mortality rates by AIDS.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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Unlike  most  other  causes  of  death,  the  mortality  due  to  AIDS  is  at  its  lowest 
among people aged 60 and over (no color on the graph means the deaths by AIDS 
among total deaths = 0%). Individuals less than 20 years old are equally not affected. 
However, the impact of AIDS on adult mortality (20-49 years) is more severe, causing 
up to 16% of the total number of deaths among the age group 30-34 years in 1995 (20% 
for  men).  This  can  be  observed  by  the  darkest  colors  (i.e.  highest  mortality)  being 
aligned with ages 30 to 40 years old. But at the end of the century, the importance of 
AIDS as a cause of death among people aged 25-44 years was already fading.   
 
Figure 11:  Proportion of deaths attributable to AIDS (in %) according to the 






























Sources: Statistique Canada, Catalogues 84-206 (1980-1986), 84-204 (1980-1986), 82-003S (1987-1989), 82-003S15 (1989-1990), 
82-003S11 (1990), 84-208 (1991-1993), 84-211 (1991-1992), 84-210-XPB (1993-1995), 84-208-XPB (1994-1995), 84-209-XPB 
(1995-1999), 84F0210XPB (1996-1997), 84F0208 (1996-1999), 84F0211XPB (1998-1999).  
                                                            
10  A Lexis figure helps visualize the trend in three dimensions: age groups, years or periods, and the level of 
intensity. The color scale circumscribes the levels of intensity of mortality.  
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3.2.7 Did mortality due to pneumonia and influenza increase? (Olshansky et al. 
1998) 
In their suggestion of a fifth stage of the epidemiologic transition, Olshansky et al. 
(1998) claim that mortality due to pneumonia and influenza increases due to population 
aging. Figure 12 displays the standardized mortality rate by pneumonia and influenza 
according to sex since 1958. The figure reveals that mortality was subject to abrupt 
variations due to the epidemic nature of influenza and pneumonia, especially during the 
first half of the period. The standardized rate follows the same trend for both sexes, the 
only difference being the higher mortality of men compared to women. Overall, the 
general trend was a decline of mortality until the end of the 1970s. During the last 
twenty years of our study, mortality fluctuated slightly but became quite stable for both 
men and women.  
 
 
Figure 12:  Standardized mortality rates by pneumonia and influenza according 





















































































Sources: Same as figure 4. 
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4. Discussion 
In conclusion, distinct stages do not emerge from the empirical Canadian mortality data 
between 1958 and 1999 to support the epidemiologic transition. Many researchers have 
hypothesized on the matter, and some of their premises were refuted, others confirmed. 
A summary of the findings is below. 
 
 
1.  Was mortality’s decline concentrated mostly in advanced ages and 
did the decline occur at nearly the same pace for males and females?  
(Olshansky and Ault 1986)  
 
-  Yes, older age groups (65 years and over) have gradually contributed 
more and more to the decline of Canadian mortality since 1958.  
-  No, the decline of mortality between 1958 and 1999 did not occur at the 
same pace for women and for men. 
2.  Did the pattern of mortality by cause become stable (Olshansky and 
Ault 1986)?  
 
-  No, standardized mortality rates did not evolve the same way among 
different causes. The proportion of deaths due to cardiovascular disease 
had historically dominated the spectrum. But over the past 50 years, that 
proportion has fallen while deaths due to tumours have grown.  
3.  Did specific changes occur within chronic disease groups?  
 
-  Yes, and the major modification was the transfer of predominance from 
digestive system tumours to respiratory system tumours. Demographic Research: Volume 18, Article 19 
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4.  Did a gradual shift towards older ages take place in mortality by 
chronic diseases? (Olshansky and Ault 1986) 
 
-  Yes,  particularly  for  chronic  obstructive  pulmonary  diseases  and  for 
diseases of the osteo-articular, muscular and conjunctive tissue system.  
However, the postponement towards older ages of death by cancer did 
not prove to be significant.  
5.  Have we observed a decline of mortality by social pathologies, more 
precisely  homicides,  suicides  and  accidents?  (Rogers  and 
Hackenberg 1987) 
 
-  Yes, especially since the middle of the 1970s.  
6.  Was the impact of AIDS on mortality significant? Did a resurgence 
of infectious diseases like cholera, diphtheria and dengue take place? 
(Omran 1998)  
         
-  No, the impact of AIDS on mortality lasted only a few years and was 
limited to men aged 20-49 years old. 
-  No,  there  was  no  resurgence  of  infectious  diseases  like  cholera, 
diphtheria and dengue. 
7.  Did mortality due to pneumonia and influenza increase? (Olshansky 
et al. 1998) 
 
-  No. Mortality due to pneumonia and influenza decreased between 1958 
and 1980, and then stabilized until the end of the century.  
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Robine (2001) as well as Meslé and Vallin (2002, 2004, 2005) studied the theory 
of  the  epidemiologic  transition,  but  their  observations  were  not  examined  in  this 
research paper. It would have been interesting to look at Robine’s redefinition of the 
third stage, called the “age of the conquest of the extent of life”. According to him, 
deaths are indeed postponed to older ages, but this would not imply a reduction in the 
dispersion of life spans. As for Meslé and Vallin (2002), their response to the traditional 
epidemiologic transition is a “sanitary transition” comprised of two stages only. They 
identify the second stage as the “cardiovascular revolution”, which is portrayed by a 
continuation  of  improvement  in  survival  mostly  imputable  to  the  decline  of 
cardiovascular diseases. This hypothesis by Meslé and Vallin is easily observable for 
Canada, as can be seen on figure 13. The prolongation of mortality’s decrease between 
1958 and 1999 was almost entirely due to the decline of mortality by cardiovascular 
diseases.  
Although Meslé and Vallin’s broader redefinition of a health transition (including 
a cardiovascular revolution as the second stage and a possible third stage described as a 
slowing down of ageing) seems the most adequate proposition, it does not account for 
the evolution of every major group of death causes.  
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Figure 13:  Standardized mortality rates for all deaths, for deaths by 
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We conclude, first, that the evolution of mortality and of the pattern of causes of death 
in Canada do not genuinely fit the theory of the epidemiologic transition and, second, 
that  the  fragmentation  of  the  theory  of  the  epidemiologic  transition  into  distinctive 
stages delimited in time proves to be inappropriate for Canada, at least since the middle 
of the last century. Rather, the epidemiologic transition of the last fifty years in Canada 
should be perceived as a continuum of the third stage during which mortality continues 
to decrease and during which chronic diseases are largely predominant. More precisely, 
the decline of mortality increasingly profited the elderly; the proportion of deaths by 
malignant  tumours  grew  while  cardiovascular  mortality  decreased  significantly;  the 
importance of respiratory system deaths (lung, bronchial tubes and windpipe cancer as 
well  as  chronic  obstructive  pulmonary  diseases),  has  been  growing  as  a  result  of 
tobacco consumption; finally, infectious and parasitic diseases have subsisted, although 
their potential threat has been modest thus far.  Lussier, Bourbeau & Choinière: The epidemiologic transition theory applied to Canadian mortality 
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